Low-risk Breast Ductal Carcinoma In Situ (DCIS): Results From the Radiation Therapy Oncology Group 9804 Phase 3 Trial

Author Disclosure: A. Chakravarti: None. M. Wang: None. K. Aldape: B. Independent Contractor; Genetech, Bristol-Myers Squibb. E. Research Grant; Astra-Zenica. E. Sulman: F. Honoraria; Merck. M. Bredel: None. M. Hegi: E. Research Grant; MDxHealth. M. Gilbert: B. Independent Contractor; Merck, Abbott, Genetech. E. Research Grant; Merck, Genetech. F. Honoraria; Merck, Genetech. W. Curran: B. Independent Contractor; BMS. E. Research Grant; Abbott. M. Werner-Wasik: None. M. Mehta: B. Independent Contractor; Bayer, Elekta, Merck, Novartis, Quarck, Tomotherapy, Vertex, BMS, USOnc. F. Honoraria; Merck, Grace, MDM, Prine Onc, Strategic Edge, WebMD. L. Stock Options; Pharmacyclis, Colby, Accuracy, Procertus, Stemina.